Literature DB >> 22776451

Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates.

Jonas Hannestad1, Jean-Dominique Gallezot, Thomas Schafbauer, Keunpoong Lim, Tracy Kloczynski, Evan D Morris, Richard E Carson, Yu-Shin Ding, Kelly P Cosgrove.   

Abstract

UNLABELLED: Microglia play an essential role in many brain diseases. Microglia are activated by local tissue damage or inflammation, but systemic inflammation can also activate microglia. An important clinical question is whether the effects of systemic inflammation on microglia mediate the deleterious effects of systemic inflammation in diseases such as Alzheimer's dementia, multiple sclerosis, and stroke. Positron Emission Tomography (PET) imaging with ligands that bind to Translocator Protein (TSPO) can be used to detect activated microglia. The aim of this study was to evaluate whether the effect of systemic inflammation on microglia could be measured with PET imaging in nonhuman primates, using the TSPO ligand [(11)C]PBR28.
METHODS: Six female baboons (Papio anubis) were scanned before and at 1h and/or 4h and/or 22 h after intravenous administration of E. coli lipopolysaccharide (LPS; 0.1mg/kg), which induces systemic inflammation. Regional time-activity data from regions of interest (ROIs) were fitted to the two-tissue compartmental model, using the metabolite-corrected arterial plasma curve as input function. Total volume of distribution (V(T)) of [(11)C]PBR28 was used as a measure of total ligand binding. The primary outcome was change in V(T) from baseline. Serum levels of tumor necrosis factor alpha (TNFα), interleukin-1 beta (IL-1β), interleukin-6 (IL-6), and interleukin-8 (IL-8) were used to assess correlations between systemic inflammation and microglial activation. In one baboon, immunohistochemistry was used to identify cells expressing TSPO.
RESULTS: LPS administration increased [(11)C]PBR28 binding (F(3,6)=5.1, p=.043) with a 29 ± 16% increase at 1h (n=4) and a 62 ± 34% increase at 4h (n=3) post-LPS. There was a positive correlation between serum IL-1β and IL-6 levels and the increase in [(11)C]PBR28 binding. TSPO immunoreactivity occurred almost exclusively in microglia and rarely in astrocytes.
CONCLUSION: In the nonhuman-primate brain, LPS-induced systemic inflammation produces a robust increase in the level of TSPO that is readily detected with [(11)C]PBR28 PET. The effect of LPS on [(11)C]PBR28 binding is likely mediated by inflammatory cytokines. Activation of microglia may be a mechanism through which systemic inflammatory processes influence the course of diseases such as Alzheimer's, multiple sclerosis, and possibly depression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22776451      PMCID: PMC3699786          DOI: 10.1016/j.neuroimage.2012.06.055

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  45 in total

1.  Characterisation of ramified microglial cells: detailed morphology, morphological plasticity and proliferative capability.

Authors:  J A Glenn; S A Ward; C R Stone; P L Booth; W E Thomas
Journal:  J Anat       Date:  1992-02       Impact factor: 2.610

2.  Progressive activation of adult microglial cells in vitro.

Authors:  N Slepko; G Levi
Journal:  Glia       Date:  1996-03       Impact factor: 7.452

3.  Intercomparison of four reconstruction techniques for positron volume imaging with rotating planar detectors.

Authors:  A J Reader; D Visvikis; K Erlandsson; R J Ott; M A Flower
Journal:  Phys Med Biol       Date:  1998-04       Impact factor: 3.609

4.  Proinflammatory cytokines increase in sepsis after anti-adhesion molecule therapy.

Authors:  K E Welty-Wolf; M S Carraway; A Ghio; S P Kantrow; Y C Huang; C A Piantadosi
Journal:  Shock       Date:  2000-05       Impact factor: 3.454

5.  MRI-PET registration with automated algorithm.

Authors:  R P Woods; J C Mazziotta; S R Cherry
Journal:  J Comput Assist Tomogr       Date:  1993 Jul-Aug       Impact factor: 1.826

6.  Phenotypic differences between human monocytes/macrophages and microglial cells studied in situ and in vitro.

Authors:  E Ulvestad; K Williams; S Mørk; J Antel; H Nyland
Journal:  J Neuropathol Exp Neurol       Date:  1994-09       Impact factor: 3.685

Review 7.  Systemic inflammation and delirium: important co-factors in the progression of dementia.

Authors:  Colm Cunningham
Journal:  Biochem Soc Trans       Date:  2011-08       Impact factor: 5.407

8.  Lipopolysaccharide dose response in baboons.

Authors:  Sandra B Haudek; Beate E Natmessnig; Walter Fürst; Soheyl Bahrami; Günther Schlag; Heinz Redl
Journal:  Shock       Date:  2003-11       Impact factor: 3.454

Review 9.  Ketamine: a review of its pharmacologic properties and use in ambulatory anesthesia.

Authors:  D A Haas; D G Harper
Journal:  Anesth Prog       Date:  1992

10.  An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28.

Authors:  David R Owen; Astrid J Yeo; Roger N Gunn; Kijoung Song; Graham Wadsworth; Andrew Lewis; Chris Rhodes; David J Pulford; Idriss Bennacef; Christine A Parker; Pamela L StJean; Lon R Cardon; Vincent E Mooser; Paul M Matthews; Eugenii A Rabiner; Justin P Rubio
Journal:  J Cereb Blood Flow Metab       Date:  2011-10-19       Impact factor: 6.200

View more
  89 in total

1.  Imaging robust microglial activation after lipopolysaccharide administration in humans with PET.

Authors:  Christine M Sandiego; Jean-Dominique Gallezot; Brian Pittman; Nabeel Nabulsi; Keunpoong Lim; Shu-Fei Lin; David Matuskey; Jae-Yun Lee; Kevin C O'Connor; Yiyun Huang; Richard E Carson; Jonas Hannestad; Kelly P Cosgrove
Journal:  Proc Natl Acad Sci U S A       Date:  2015-09-18       Impact factor: 11.205

2.  Microglial Activity in People at Ultra High Risk of Psychosis and in Schizophrenia: An [(11)C]PBR28 PET Brain Imaging Study.

Authors:  Peter S Bloomfield; Sudhakar Selvaraj; Vincenzo de Paola; Oliver D Howes; Mattia Veronese; Gaia Rizzo; Alessandra Bertoldo; David R Owen; Michael Ap Bloomfield; Ilaria Bonoldi; Nicola Kalk; Federico Turkheimer; Philip McGuire
Journal:  Am J Psychiatry       Date:  2015-10-16       Impact factor: 18.112

Review 3.  Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?

Authors:  Mark J Niciu; Ioline D Henter; Gerard Sanacora; Carlos A Zarate
Journal:  World J Biol Psychiatry       Date:  2013-09-12       Impact factor: 4.132

4.  Peripheral Immune System Adaptations and Motivation for Alcohol in Non-Dependent Problem Drinkers.

Authors:  Verica Milivojevic; Emily Ansell; Christine Simpson; Kristen M Siedlarz; Rajita Sinha; Helen C Fox
Journal:  Alcohol Clin Exp Res       Date:  2017-02-01       Impact factor: 3.455

Review 5.  Microglial priming in Alzheimer's disease.

Authors:  Jun-Wei Li; Yu Zong; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

6.  Neuroinflammation in treated HIV-positive individuals: A TSPO PET study.

Authors:  Jaime H Vera; Qi Guo; James H Cole; Adriano Boasso; Louise Greathead; Peter Kelleher; Eugenii A Rabiner; Nicola Kalk; Courtney Bishop; Roger N Gunn; Paul M Matthews; Alan Winston
Journal:  Neurology       Date:  2016-02-24       Impact factor: 9.910

7.  Assessment of simplified methods for quantification of [18F]-DPA-714 using 3D whole-brain TSPO immunohistochemistry in a non-human primate.

Authors:  Nadja Van Camp; Yaël Balbastre; Anne-Sophie Herard; Sonia Lavisse; Clovis Tauber; Catriona Wimberley; Martine Guillermier; Aurélie Berniard; Pauline Gipchtein; Caroline Jan; Romina Aron Badin; Thierry Delzescaux; Philippe Hantraye; Gilles Bonvento
Journal:  J Cereb Blood Flow Metab       Date:  2019-06-25       Impact factor: 6.200

Review 8.  Imaging Biomarkers of the Neuroimmune System among Substance Use Disorders: A Systematic Review.

Authors:  Eric A Woodcock; Ansel T Hillmer; Graeme F Mason; Kelly P Cosgrove
Journal:  Mol Neuropsychiatry       Date:  2019-05-09

9.  Microglia and schizophrenia: where next?

Authors:  T Notter; U Meyer
Journal:  Mol Psychiatry       Date:  2017-03-28       Impact factor: 15.992

Review 10.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.